Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02247934 · ClinicalTrials.gov registry record
Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
A clinical trial, sponsored by Gilead Sciences.
- Completed
- Registry status
- 26
- Enrollment target
NCT02247934 is a clinical trial that has completed, run by Gilead Sciences. The registered enrollment target is 26 participants.
The verdict
NCT02247934 has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02247934
The ClinicalTrials.gov registry entry for NCT02247934 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02247934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02247934 about?
NCT02247934 is a clinical study titled "Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)". The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.
What is the current status of trial NCT02247934?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-10. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT02247934?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.